DCOY
Decoy Therapeutics Inc.
NASDAQ: DCOY · HEALTHCARE · BIOTECHNOLOGY
$5.54
+1.19% today
Updated 2026-04-29
Market cap
$2.89M
P/E ratio
—
P/S ratio
15.86x
EPS (TTM)
$-129.10
Dividend yield
—
52W range
$5 – $239
Volume
0.1M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$30.00
+441.52%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.14M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-31.61M | $-12.54M | $-5.58M | $-12.52M | $-8.98M |
| EPS | — | — | — | — | $-129.10 |
| Free cash flow | $-19.10M | $-12.85M | $-4.53M | $-5.40M | $-1.14M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Decoy Therapeutics Inc. trades at $5.54. Our Smart Value Score of 26/100 indicates the stock is weak.
Frequently asked questions
What is Decoy Therapeutics Inc.'s stock price?
Decoy Therapeutics Inc. (DCOY) trades at $5.54.
Is Decoy Therapeutics Inc. overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Decoy Therapeutics Inc. (DCOY)?
The analyst target price is $30.00, representing +441.5% upside from the current price of $5.54.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio15.86x
ROE-338.30%
Beta0.37
50D MA$7.24
200D MA$36.38
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—